These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3105631

  • 1. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
    Hetherington JW, Newling DW, Robinson MR, Smith PH, Adib RS, Whelan P.
    Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
    [Abstract] [Full Text] [Related]

  • 2. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
    MacFarlane JR, Tolley DA.
    Br J Urol; 1985 Feb; 57(1):37-9. PubMed ID: 3918605
    [Abstract] [Full Text] [Related]

  • 3. [Local mitomycin-C therapy of infiltrating bladder cancer].
    Erdmann WD, Harzmann R, Flüchter SH, Bichler KH.
    Fortschr Med; 1984 Aug 16; 102(29-30):767-71. PubMed ID: 6437950
    [Abstract] [Full Text] [Related]

  • 4. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA, Van Helsdingen PJ, Kramer AE.
    Br J Urol; 1989 Feb 16; 63(2):176-9. PubMed ID: 2495144
    [Abstract] [Full Text] [Related]

  • 5. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO, Giuliano F.
    Ann Urol (Paris); 1988 Feb 16; 22(6):404-6. PubMed ID: 3146942
    [Abstract] [Full Text] [Related]

  • 6. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH, Lee C.
    J Urol; 1989 Jun 16; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.
    Harrison GS, Green DF, Newling DW, Richards B, Robinson MR, Smith PH.
    Br J Urol; 1983 Dec 16; 55(6):676-9. PubMed ID: 6418263
    [Abstract] [Full Text] [Related]

  • 8. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr 16; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Tolley DA, Hargreave TB, Smith PH, Williams JL, Grigor KM, Parmar MK, Freedman LS, Uscinska BM.
    Br Med J (Clin Res Ed); 1988 Jun 25; 296(6639):1759-61. PubMed ID: 3136828
    [Abstract] [Full Text] [Related]

  • 10. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
    Heney NM, Koontz WW, Barton B, Soloway M, Trump DL, Hazra T, Weinstein RS.
    J Urol; 1988 Dec 25; 140(6):1390-3. PubMed ID: 3143016
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A, Eidelman A, Barak F, Alon H, Horn Y.
    J Surg Oncol; 1989 May 25; 41(1):9-11. PubMed ID: 2497274
    [Abstract] [Full Text] [Related]

  • 12. Mitomycin C in superficial bladder cancer: 24-month follow-up.
    Somerville JJ, Newling DW, Richards B, Robinson MR, Smith PH.
    Br J Urol; 1985 Dec 25; 57(6):686-9. PubMed ID: 3936564
    [Abstract] [Full Text] [Related]

  • 13. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
    Schwarzman MI, Johanson KE, Surya B, Brown J.
    Urology; 1988 Oct 25; 32(4):335-8. PubMed ID: 3140465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
    Milani C, Bassi PF, Meneghini A, Giunta A, Tejerizo JC, dal Bianco M, Zattoni F, Garbeglio A.
    Arch Esp Urol; 1989 Oct 25; 42(8):761-7. PubMed ID: 2515812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study.
    Kondás J, Kiss L, Határ A, Kiss A, Lukács T, Szeldeli P, Törzsök F, Bodrogi I.
    Int Urol Nephrol; 1999 Oct 25; 31(4):451-6. PubMed ID: 10668939
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
    J Urol; 1982 Jun 25; 127(6):1096-8. PubMed ID: 6806488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.